Sonoma Biotherapeutics, a life sciences company developing treatments for autoimmune diseases, announced this week it raised $265 million to grow its operations in Seattle and the San Francisco Bay Area. Sonoma is one of many life science companies building operations in multiple cities. Last year, Sonoma signed a lease for an 11,000-square-foot lab facility in Seattle. The company's founders and employees are split between Washington and California.